Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate ---
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
Duck Creek Technologies Acquires Risk Control Technologies to Deliver Comprehensive Risk Management and Mitigation Solutions
Acronis External Survey of Women in the IT Workforce finds 71% of Females Work Longer Hours to Advance Their Careers